Cases with Parkinson’s disease had a smaller consumption of glucose lowering drugs excluding insulins, antihypertensive drugs and cholesterol lowering drugs compared to cases without Parkinson’s disease, as well as a longer duration of diabetes (P < 0.001). This evidence concerns the gene INS and Parkinson disease.